HBC — Hofseth Biocare ASA Share News
0.000.00%
Last trade - 00:00- NOK513.85m
- NOK746.89m
- NOK256.34m
Brief: Hofseth Biocare Says Private Placement Significantly Oversubscribed
Brief: Hofseth Biocare: New Study Shows Potential Of Omego As Therapy For Asthma And COPD
Brief: Hofseth Biocare Q2 EBITDA Loss NOK 17.3 Million
Brief: Hofseth Biocare Secures Distribution With Global Retailer Giant In UK, Spain, Iceland
Brief: Hofseth Biocare Buys 34% Stake In Atlantic Delights
Brief: Hofseth Biocare ASA: HBC Has Begun Protocol Development For Its Accelerated Phase 2 Clinical Trial
Brief: Hofseth Biocare: Preclinical Research With OmeGo Demonstrates Potential To Treat Eosinophilic Asthma
Brief: Hofseth Biocare ASA - Operating Revenues Of Nok 18.5 mln Q1 Of 2020
Brief: Hofseth Biocare: Two-Year Research Collaboration Contract Signed With Stanford
Australia's Clean Seas Seafood rises on investment from Norway-based Hofseth
Brief: Hofseth Biocare Raises NOK 21.9 Mln In Private Placement
Brief: Hofseth Biocare Signs EU Distribution Agreement With Prinova Europe
Brief: Hofseth Biocare Q4 EBITDA Loss Widens To NOK 15.0 Mln
Brief: Hofseth BioCare Signs Working Capital Credit Line Of NOK 37 Mln
Brief: Hofseth Biocare Says Atlantic Sapphire And Co Sign LOI To Establish Joint Venture In Miami, U.S.
Brief: Hofseth Biocare Q3 EBITDA Loss Narrows To NOK 7.6 Mln
Brief: Hofseth Biocare Enters Into Consultancy Agreement With James Berger, Contemplates US Listing
Brief: Hofseth Biocare Gets Protein Hydrolysis Patent From European Patent Office
Brief: Hofseth Biocare Says Brilliant Invest Purchased 11 Mln Shares In Co From Hofseth International